Atlas Trials

Pilot Study on the Clinical Efficacy of Focused Ultrasound-Mediated Targeted Drug Delivery System Combined With Neoadjuvant Therapy for HER2-Positive Breast Cancer

Clinical trial NCT07616440 · RECRUITING

Trial details

NCT number
NCT07616440
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
HER2-positive Breast Cancer
Start date
2026-06-01
Primary completion
2027-01-31
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.